Sharemaestro company-news research for BrightSpring Health Services, Inc. Common Stock (BTSG), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

NASDAQ United States Measured evidence

Company news sentiment

BTSG news sentiment

BrightSpring Health Services, Inc. Common Stock

Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.

Weighted tone68Neutral is 50
Constructive news tone 70/100 evidence confidence 100% direct company focus 6 current stories across 1 publishers
Latest weekly closeUSD 62.43week of 7 Aug 2026
Dominant catalystEarnings85/100 classification confidence
News data statusHealthy1 duplicate stories removed

Current company news

News confirmed by price

Constructive news tone is drawn from 6 fresh independent stories, including 6 company-specific items across 1 publishers.

Latest source headline Here's Why You Should Add BrightSpring Stock to Your Portfolio Now finance.yahoo.com · 12 Aug 2026 15:41

What supports the read

Direct evidence

6 current stories are mapped specifically to BTSG.

Narrative agreement

Cross-story agreement is 80/100, indicating a comparatively coherent tape.

Price response

Constructive news tone is being confirmed by positive weekly price action.

What tempers the read

Source breadth

Only 1 publisher currently contribute to the measured read.

68/100
Weighted toneConstructive news tone
70/100
Evidence confidencesolid confidence
100%/100
Company focus6 direct stories
80/100
Evidence agreement20/100 dispersion

News history

Tone and story flow over 21 days

Daily weighted evidence
08 Aug: 1 stories09 Aug: 1 stories11 Aug: 1 stories12 Aug: 3 stories 08 Aug: tone 61, 1 stories09 Aug: tone 86, 1 stories11 Aug: tone 34, 1 stories12 Aug: tone 89, 3 stories 95505
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50

Evidence confidence

What supports the score

Measured separately from tone

Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.

Sample depth74
5.89 effective stories
Source breadth20
1 independent publishers
Direct relevance100
company-specific evidence share
Freshness77
recency-weighted evidence
Agreement80
cross-story consistency
Source independence0
lower publisher concentration

Price context

Sentiment against the 26-week price path

News confirmed by price

Constructive news tone is being confirmed by positive weekly price action.

13 Feb 2026: close 38.86, indexed 100.020 Feb 2026: close 41.06, indexed 105.727 Feb 2026: close 41.43, indexed 106.606 Mar 2026: close 41.49, indexed 106.813 Mar 2026: close 38.31, indexed 98.620 Mar 2026: close 41.21, indexed 106.027 Mar 2026: close 42.33, indexed 108.903 Apr 2026: close 43.1, indexed 110.910 Apr 2026: close 45.33, indexed 116.617 Apr 2026: close 47.27, indexed 121.624 Apr 2026: close 48.16, indexed 123.901 May 2026: close 52.58, indexed 135.308 May 2026: close 54.83, indexed 141.115 May 2026: close 57.9, indexed 149.022 May 2026: close 58.5, indexed 150.529 May 2026: close 61.68, indexed 158.705 Jun 2026: close 57.4, indexed 147.712 Jun 2026: close 63.23, indexed 162.719 Jun 2026: close 66.25, indexed 170.526 Jun 2026: close 68.98, indexed 177.503 Jul 2026: close 69.03, indexed 177.610 Jul 2026: close 71.43, indexed 183.817 Jul 2026: close 70.69, indexed 181.924 Jul 2026: close 72.91, indexed 187.631 Jul 2026: close 59.71, indexed 153.707 Aug 2026: close 62.43, indexed 160.7 26 Jun 2026: sentiment 5727 Jun 2026: sentiment 5728 Jun 2026: sentiment 5729 Jun 2026: sentiment 5729 Jun 2026: sentiment 5630 Jun 2026: sentiment 5602 Jul 2026: sentiment 5602 Jul 2026: sentiment 5602 Jul 2026: sentiment 5603 Jul 2026: sentiment 5604 Jul 2026: sentiment 5604 Jul 2026: sentiment 5605 Jul 2026: sentiment 5605 Jul 2026: sentiment 5606 Jul 2026: sentiment 5607 Jul 2026: sentiment 5610 Jul 2026: sentiment 5711 Jul 2026: sentiment 5712 Jul 2026: sentiment 5715 Jul 2026: sentiment 5716 Jul 2026: sentiment 5818 Jul 2026: sentiment 5819 Jul 2026: sentiment 5819 Jul 2026: sentiment 5819 Jul 2026: sentiment 5720 Jul 2026: sentiment 5721 Jul 2026: sentiment 5822 Jul 2026: sentiment 5722 Jul 2026: sentiment 5722 Jul 2026: sentiment 5823 Jul 2026: sentiment 5724 Jul 2026: sentiment 5724 Jul 2026: sentiment 5727 Jul 2026: sentiment 5728 Jul 2026: sentiment 5728 Jul 2026: sentiment 5729 Jul 2026: sentiment 5729 Jul 2026: sentiment 5729 Jul 2026: sentiment 5829 Jul 2026: sentiment 5729 Jul 2026: sentiment 5730 Jul 2026: sentiment 5830 Jul 2026: sentiment 5730 Jul 2026: sentiment 5731 Jul 2026: sentiment 5731 Jul 2026: sentiment 5731 Jul 2026: sentiment 5731 Jul 2026: sentiment 5701 Aug 2026: sentiment 5601 Aug 2026: sentiment 5610 Aug 2026: sentiment 6211 Aug 2026: sentiment 62
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
26-week price+60.7%latest close 62.43
Sentiment change+5available snapshot window
One-week response+4.6%Price confirming higher
Fair-value position+134.2%Materially above fair value
Sentiment confirms active trendPositive but stretched

News subjects

What is shaping the score

Earnings
Earnings766 stories · 100%

Source mix

Where the evidence comes from

0/100 independence
finance.yahoo.com766 stories · 100%

Recurring subjects

Subjects appearing most often

Current evidence
Earnings5Guidance4Healthcare3Earnings Per Share3Revenue Growth2Free Cash Flow2Earnings Growth2Return On Equity1Regulation1Ratings1

Earlier readings

How the score has changed

50 is the neutral baseline
ConstructiveBalanced or withheldCautious

Source headlines

The news behind the score

Showing 1-6 of 6

Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.

#187Tone
finance.yahoo.comDirect company coverage

Here's Why You Should Add BrightSpring Stock to Your Portfolio Now

BrightSpring Health Services, Inc. BTSG is well-poised for growth in the coming quarters, backed by strong momentum in Provider Services, expanding specialty and infusion operations, successful integration of acquired home health assets and a scalable home-based care platform. However, the Inflation Reduction Act (IRA)-related reimbursement pressure, brand-to-generic conversion headwinds and customer exits in Home and Community Pharmacy could create uneven growth trends and weigh on near-term margin realization through 2026. This Zacks Rank #1 (Strong Buy) company's shares have rallied 54.6% i

EarningsEarnings GrowthEarnings Per ShareGuidanceHealthcareRatings
Published
12 Aug 2026 15:41
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#290Tone
finance.yahoo.comDirect company coverage

IQV Stock Gains 42% in 3 Months: Here's What You Should Know

IQVIA Holdings Inc. IQV stock has rallied over the past three months. The company's shares have jumped 41.5%, outperforming the industry's 17.2% growth and the Zacks S&P 500 Composite's 3.4% uptick. 3-Month Share Price PerformanceZacks Investment Research Image Source: Zacks Investment Research Let us delve into the factors that have contributed to the company's outperformance. Record Net Bookings & Solid Backlogs IQVIA's net new bookings were $3.2 billion for research and development solutions (R&DS) in the second quarter of 2026. It marked 19% year-over-year growth, resulting in a book-to-bi

EarningsEarnings GrowthEarnings Per ShareEarnings SurpriseGuidanceIntrinsic Value
Published
12 Aug 2026 13:09
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#389Tone
finance.yahoo.comDirect company coverage

3 Mid-Cap Stocks with Solid Fundamentals

3 Mid-Cap Stocks with Solid Fundamentals In today's market, large companies dominate the landscape and grow their leads by acquiring smaller competitors - a trend that will accelerate with the Trump administration. However, some mid-sized players will continue thriving because they've carved durable niches for themselves. Digging up these buried treasures isn't easy, and that's exactly why we created StockStory. That said, here are three of our favorite mid-cap stocks that could be the next 50 baggers. BrightSpring Health Services (BTSG) Market Cap: $13.07 billion Founded in 1974, BrightSpring

BanksFinancialsFree Cash FlowHealthcareReturn On EquityRevenue Growth
Published
12 Aug 2026 06:29
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#434Tone
finance.yahoo.comDirect company coverage

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

Hims & Hers Health, Inc. HIMS reported quarterly adjusted loss per share of 10 cents in second-quarter 2026, against the year-ago period's adjusted earnings per share (EPS) of 17 cents. The metric was wider than the Zacks Consensus Estimate of loss per share of 7 cents. GAAP loss per share for the quarter was 37 cents against the year-ago period's EPS of 17 cents. HIMS' Revenues in Detail Hims & Hers registered revenues of $753.2 million in the second quarter, up 38.2% year over year. The figure surpassed the Zacks Consensus Estimate by 9.1%. Solid revenues from both geographic segments drove

EarningsEarnings Per ShareGrowth RateGuidanceHealthcareQuarterly Results
Published
11 Aug 2026 17:19
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#586Tone
finance.yahoo.comDirect company coverage

5 Revealing Analyst Questions From BrightSpring Health Services’s Q2 Earnings Call

5 Revealing Analyst Questions From BrightSpring Health Services's Q2 Earnings Call BrightSpring Health Services delivered revenue and adjusted profit above Wall Street expectations in Q2, but the market's negative reaction reflected concerns about underlying headwinds. Management attributed strong year-over-year growth to continued expansion in its Specialty and Infusion pharmacy business, alongside disciplined operational execution and efficiency gains from technology investments. CEO Jon Rousseau detailed that "our Specialty and Infusion business delivered revenue growth of 30% and script gr

EarningsGuidanceInfusion PharmacyM ARegulationRevenue Growth
Published
09 Aug 2026 23:09
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#661Tone
finance.yahoo.comDirect company coverage

BrightSpring Health (BTSG) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Friday, July 31, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Investor Relations - David Deuchler Chief Executive Officer - Jon Rousseau Chief Financial Officer - Jennifer Phipps Full Conference Call Transcript Operator: Thank you for standing by, and welcome to BrightSpring Health Services Second Quarter 2026 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to David Deuchler, Investor Relations. Please go ahead. David Deuchler: Good morning. Thank you for participating in today's conference call. My name is David Deuchler w

AcquisitionsBalance SheetCredit RatingEarningsFinancial ResultsFree Cash Flow
Published
08 Aug 2026 02:43
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
2 consolidated

How the page works

How to read the score

Tone is directional

It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

Classification, not prediction

The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.

Evidence context